Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Cash Flow-to-Debt Ratio
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-23.58 Million could theoretically repay 0% of its total liabilities (CN¥1.46 Billion) in one year. Explore 300181 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Zhejiang Jolly Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Also explore 300181 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Zhejiang Jolly Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Zhejiang Jolly Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | CN¥411.80 Million | CN¥1.47 Billion | ▲ +10.6% |
| 2024 | 0.25x | CN¥297.05 Million | CN¥1.17 Billion | ▼ -25.1% |
| 2023 | 0.34x | CN¥288.46 Million | CN¥853.09 Million | ▼ -6.7% |
| 2022 | 0.36x | CN¥318.59 Million | CN¥879.19 Million | ▲ +10.1% |
| 2021 | 0.33x | CN¥251.80 Million | CN¥765.31 Million | ▼ -11.7% |
| 2020 | 0.37x | CN¥279.69 Million | CN¥750.43 Million | ▲ +85.8% |
| 2019 | 0.20x | CN¥128.94 Million | CN¥642.86 Million | ▲ +86.1% |
| 2018 | 0.11x | CN¥78.28 Million | CN¥726.50 Million | ▲ +996.5% |
| 2017 | 0.01x | CN¥6.51 Million | CN¥662.06 Million | ▼ -90.5% |
| 2016 | 0.10x | CN¥58.30 Million | CN¥566.00 Million | ▼ -56.0% |
| 2015 | 0.23x | CN¥97.13 Million | CN¥414.94 Million | ▲ +429.4% |
| 2014 | 0.04x | CN¥13.70 Million | CN¥309.75 Million | ▼ -74.6% |
| 2013 | 0.17x | CN¥29.50 Million | CN¥169.38 Million | ▼ -9.6% |
| 2012 | 0.19x | CN¥30.51 Million | CN¥158.27 Million | ▲ +125.9% |
| 2011 | 0.09x | CN¥13.65 Million | CN¥159.99 Million | ▼ -81.4% |
| 2010 | 0.46x | CN¥64.78 Million | CN¥141.47 Million | ▲ +37.8% |
| 2009 | 0.33x | CN¥43.89 Million | CN¥132.07 Million | ▲ +39.5% |
| 2008 | 0.24x | CN¥31.16 Million | CN¥130.76 Million | ▲ +58.6% |
| 2007 | 0.15x | CN¥16.05 Million | CN¥106.79 Million | — |